Second Line Capital, LLC Abbott Laboratories Transaction History
Second Line Capital, LLC
- $367 Billion
- Q3 2024
A detailed history of Second Line Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Second Line Capital, LLC holds 2,441 shares of ABT stock, worth $276,907. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,441Holding current value
$276,907% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,187Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.7 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.46 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.05 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...